SCHEMBL93135

SCHEMBL93135

CCN([C]=O)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL93284 0.77
SCHEMBL93172 0.75
SCHEMBL5235256 0.75 DNM1 (0.36)
SCHEMBL41939 0.73
SCHEMBL7964318 0.71 DNM1 (0.44)
SCHEMBL3710180 0.71
SCHEMBL7967425 0.69 DNM1 (0.48)
SCHEMBL3469248 0.63 CA1 (0.31)
SCHEMBL8128135 0.63 CA1 (0.31)
SCHEMBL27267 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023230557-A2 MOBILE GENETIC ELEMENTS FROM EPTESICUS FUSCUS SALIOGEN THERAPEUTICS, INC. (US) 2023-11-30 WO claimed
CN-112107568-B Diaryl amide compound and application thereof 北京龙嘉博创医药科技有限公司 2022-03-25 CN claimed
US-20210161825-A1 CHLOROQUINE-BASED MATERIALS FOR THE TREATMENT OF DISEASES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-06-03 US claimed
WO-2019200284-A1 CHLOROQUINE-BASED MATERIALS FOR THE TREATMENT OF DISEASES BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 2019-10-17 WO claimed
EP-2318006-B1 NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS NIVALIS THERAPEUTICS INC (US) 2016-10-12 EP claimed
US-9138427-B2 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents NIVALIS THERAPEUTICS, INC. (US) 2015-09-22 US claimed
EP-2426123-B1 PYRAZOLE-BASED CYANINE DYE CONTAINING QUATERNARY AMMONIUM CATION WAKO PURE CHEM IND LTD (JP) 2014-08-06 EP claimed
US-20140194425-A1 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents N30 PHARMACEUTICALS, INC. (US) 2014-07-10 US claimed
US-8546586-B2 Pyrazole-based cyanine dye containing quaternary ammonium cation WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2013-10-01 US claimed
US-8344018-B2 Oxindolyl inhibitor compounds GILEAD SCIENCES, INC. (US) 2013-01-01 US claimed
WO-2000044216-A2 GAMBOGIC ACID, ANALOGS AND DERIVATIVES AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS CYTOVIA INC (US) 2000-08-03 WO claimed
US-5773428-A BONE DISORDERS SYNTEX (U.S.A.) INC. (US) 1998-06-30 US claimed
EP-0807114-A1 BRIDGED INDOLES AS MATRIX METALLOPROTEASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1997-11-19 EP claimed
WO-1996023791-A1 BRIDGED INDOLES AS MATRIX METALLOPROTEASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1996-08-08 WO claimed
EP-0596929-B1 AMIDE DERIVATIVES OF ANTIBIOTIC A 40926 LEPETIT SPA (IT) 1995-07-26 EP claimed
EP-0596929-A1 AMIDE DERIVATIVES OF ANTIBIOTIC A 40926. LEPETIT SPA (IT) 1994-05-18 EP claimed
WO-1993003060-A1 AMIDE DERIVATIVES OF ANTIBIOTIC A 40926 GRUPPO LEPETIT S.P.A. (IT) 1993-02-18 WO claimed
EP-0525499-A1 Amide derivatives of antibiotic A 40926 GRUPPO LEPETIT S.p.A. (IT) 1993-02-03 EP claimed
US-4935543-A AROMATASE INHIBITOR TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1990-06-19 US claimed
EP-0342665-A2 Physiologically active substance tan-931, its derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1989-11-23 EP claimed